1a,25-Dihydroxyvitamin D 3 (1a,25(OH) 2 D 3 ), the active metabolite of vitamin D 3 , mediates anti-proliferative eects in cells by regulating the expression of 1a,25(OH) 2 D 3 -responsive genes. The expression of the proliferation-promoting Immediate Early gene X71 (IEX-1) is reduced by 1a,25(OH) 2 D 3 through unknown mechanisms. Here we report the presence of a novel inhibitory hexameric repeat DNA response element in the promoter of the human IEX-1 gene that mediates 1a,25(OH) 2 D 3 -associated IEX-1 gene repression. To localize a vitamin D sensitive DNA response element we transfected the keratinocyte-like cell line, HaCaT, (referred as HaCaT) with a series of plasmids containing full-length and truncated IEX-1 promoter elements fused to the luciferase reporter gene in the absence or presence of 1a,25(OH) 2 D 3 , and we performed electrophoretic gel mobility assays in the presence of receptors for 1a,25(OH) 2 D 3 (vitamin D receptor, VDR) and 9-cisretinoic acid (RXRa). We mapped a negative response element between nt 7405 and 7391(15 bp) of the IEX-1 promoter (5'-TGAACC AGG GAGTCA-3') that mediates transcriptional inhibition in response to 1a,25(OH) 2 D 3 and which requires expression of both nuclear receptors for 1a,25(OH) 2 D 3 and 9-cis-retinoic acid. Our data indicate that the physiological repression of IEX-1 gene expression by 1a,25(OH) 2 D 3 is directly mediated by nuclear VDR/RXRa heterodimers through a speci®c transcriptional element.
1a,25-Dihydroxyvitamin D 3 (1a,25(OH) 2 D 3 ), the active metabolite of vitamin D 3 , mediates anti-proliferative eects in cells by regulating the expression of 1a,25(OH) 2 D 3 -responsive genes. The expression of the proliferation-promoting Immediate Early gene X71 (IEX-1) is reduced by 1a,25(OH) 2 D 3 through unknown mechanisms. Here we report the presence of a novel inhibitory hexameric repeat DNA response element in the promoter of the human IEX-1 gene that mediates 1a,25(OH) 2 D 3 -associated IEX-1 gene repression. To localize a vitamin D sensitive DNA response element we transfected the keratinocyte-like cell line, HaCaT, (referred as HaCaT) with a series of plasmids containing full-length and truncated IEX-1 promoter elements fused to the luciferase reporter gene in the absence or presence of 1a,25(OH) 2 D 3 , and we performed electrophoretic gel mobility assays in the presence of receptors for 1a,25(OH) 2 D 3 (vitamin D receptor, VDR) and 9-cisretinoic acid (RXRa). We mapped a negative response element between nt 7405 and 7391(15 bp) of the IEX-1 promoter (5'-TGAACC AGG GAGTCA-3') that mediates transcriptional inhibition in response to 1a,25(OH) 2 D 3 and which requires expression of both nuclear receptors for 1a,25(OH) 2 D 3 and 9-cis-retinoic acid. Our data indicate that the physiological repression of IEX-1 gene expression by 1a,25(OH) 2 D 3 is directly mediated by nuclear VDR/RXRa heterodimers through a speci®c transcriptional element.
Introduction
Vitamin D 3 , via its hormonal metabolite, 1a,25(OH) 2 D 3 , plays an important role in cellular growth, dierentiation and gene regulation (Kumar, 1991; Pike, 1991; Norman et al., 1992; Wasserman et al., 1992; Cai et al., 1993) . 1a,25(OH) 2 D 3 interacts with the vitamin D receptor (VDR) to activate or repress various genes (Evans, 1988; Haussler et al., 1988 Haussler et al., , 1998 . The eects of 1a,25(OH) 2 D 3 are primarily mediated by the vitamin D nuclear receptor (VDR) which is a member of the large family of nuclear ligand-activated receptors that function as transcription factors. The VDR is a 48 kDa zinc-®nger protein (Norman et al., 1992; Darwish and DeLuca, 1993; Haussler et al., 1998) , which activates transcription by binding to vitamin D response elements (VDREs) within the promoter of vitamin D responsive genes, either as a homodimer (Forman et al., 1992; Carlberg et al., 1993) or a heterodimer with the retinoic acid X receptor a (RXRa) (Kliewer et al., 1992; Zhang et al., 1992; Craig et al., 1999) , retinoic acid receptor (RAR) (Glass et al., 1989; Schrader et al., 1993 Schrader et al., , 1994 , or thyroid hormone receptor (T 3 R) (Schrader et al., 1994) . 1a,25(OH) 2 D 3 -mediated retardation of cellular growth and apoptosis have been reported in various cells treated with the hormone (Gross et al., 1986; Itin et al., 1994; Haugen et al., 1996; Elstner et al., 1996; James et al., 1996; Simboli-Campbell et al., 1996 Wu et al., 1997; Narvaez and Welsh, 1997) . The mechanisms by which 1a,25(OH) 2 D 3 alters cell proliferation are complicated and this steroid hormone may control functionally distinct intersecting and/or compensatory signaling pathways to regulate cellular growth. Several studies have shown that growth factors play an important role in this process (SimboliCampbell et al., 1994; Haugen et al., 1996; Wu et al., 1997; Veenstra et al., 1998b) . For example, in HaCaT and osteoblast cells, 1a,25(OH) 2 D 3 causes an increase in TGF-b2 protein synthesis that is associated with a decrease in the growth rate of these cells (Haugen et al., 1996; Wu et al., 1997) . Other mechanisms that might have been involved in the regulation of cell proliferation by 1a,25(OH) 2 D 3 include changes in the expression of immediate early genes such as c-myc, p21/Waf/CIP1, alterations in protein kinase C activity and changes in polyamine synthesis (van Leeuwen et al., 1992; Simboli-Campbell et al., 1994; Liu et al., 1996a) .
To de®ne the factors that regulate the anti-mitogenic and dierentiation promoting eects of 1a,25(OH) 2 D 3 , we previously performed dierential display PCR in cells treated with the 1a,25(OH) 2 D 3 and showed that the expression of a proliferation-speci®c factor, IEX-1 was inhibited at the level of transcription in HaCaT cells 
Results

Identification of a vitamin D response element in the human IEX-1 promoter region
To detect and localize DNA sequences in the IEX-1 promoter responsible for 1a,25(OH) 2 D 3 -mediated repression at the transcriptional level, we performed transient transfection assays using a series of 5'-promoter region deletion constructs which contained various lengths of the IEX-1 promoter sequence fused to the ®re¯y luciferase reporter gene. These IEX-1 promoter constructs encode multiple putative recognition motifs for distinct classes of transcription factors and a TATA box sequence located 25 bp upstream from the transcriptional initiation site (Figure 1 ). IEX-1 promoter deletion constructs were fused to ®re¯y luciferase reporter gene in the plasmid pGL3-basic and were transiently transfected into HaCaT cells. Figure 2) . 1a,25(OH) 2 D 3 is known to activate or repress the transcription of several genes by binding to and activating the VDR. The VDR has been shown to bind to speci®c DNA sequences known as vitamin D response elements (VDRE) either as a homodimer or heterodimer with RXR/RXRa. VDREs are usually composed of direct repeats, palindromes or inverted palindromes of hexameric core binding motif RRKNSA (R=A or G, K=G or T, S=C or G). We found a putative VDRE containing two steroid hormone response elements (HRE), in opposite orientation and three base pair apart from each other in the human IEX-1 promoter extending from 7405 and 7391 (15 bp). The sequence is 5'-TGAACC AGG GAGTCA-3'. The complement of the ®rst HRE sequence is 5'-GGTTCA-3' and is identical to the half-site HREs of the mouse osteopontin (Noda et al., 1990) , rat 24-hydroxylase (Zierold et al., 1994) , Cdk inhibitor, p21 (Liu et al., 1996) and human PTH (Demay et al., 1992; Mackey et al., 1996) genes. The 3' hexameric motif GAGTCA resembles the canonical hormone response element, RRKNSA (Wu et al., 1999) . We performed site-directed mutagenesis of this putative VDRE by replacing both core binding motifs, TGAACC and GAGTCA with SalI restriction enzyme site (5'-GTCGAC-3'), generating IEX-1 promoter mutant constructs, mVDRE/71419 and mVDRE/ 7575. We performed luciferase activity assays after transient transfection of these mutant constructs into HaCaT cells. The promoter activity of the mutant constructs, mVDRE/71419 and mVDRE/7575, is approximately 2 ± 5-fold higher when compared to the values of the corresponding wild type promoters ( Figure 3 ). This observation indicates that the promoter sequence between 7405 and 7391 bp functions as a repressor element that interacts with a negative regulator of IEX-1 transcription under basal conditions, perhaps due to low hormone levels present in culture media supplemented with bovine serum. More importantly, both IEX-1 promoter mutants failed to respond to the addition of 1a,25(OH) 2 D 3 compound even after overexpression of both VDR and RXRa ( Figure 4 ). Taken together, these results indicate that the repression of IEX-1 transcription is mediated by 1a,25(OH) 2 D 3 via the VDRE present in the IEX-1 promoter region.
VDRE/RXRa heterodimer formation is required to mediate IEX-1 gene repression
To elucidate the transcriptional mechanism of IEX-1 gene expression and, in particular, the contribution of the 7405 and 7391 bp region to the promoter activity, we performed electrophoretic mobility shift assays (EMSA) using puri®ed full-length hVDR and hRXRa proteins expressed in E. coli. Protein binding was also not observed with the corresponding mutant oligonucleotides (mutVDRE) ( Figure 5 ). The DNA-protein interaction was speci®c, because a 20-fold molar excess of unlabeled oligonucleotides, VDRE/IEX-1 or mouse osteopontin vitamin D response element (mOP-VDRE) abolished the complex formation while, a 20-fold molar excess of unlabeled mutant oligonucleotides (mutVDRE) failed to inhibit the DNA-protein complex formation ( Figure  5 ). These results suggest that the VDRE present in human IEX-1 promoter region requires the presence of the both proteins, hVDR and hRXRa to mediate transcriptional repression of IEX-1 gene expression. These gel shift assays are in agreement with our transient transfection study of the luciferase-fused IEX- Right-luciferase activity is shown as n-fold value compared to cells transfected with the promoterless pGL3-basic vector (which was assigned an activity value of 1.0). Data represent the means of three independent experiments in duplicates, with at least two dierent plasmid preparations 1 promoter construct activities in which co-expression of the both nuclear receptors are required for the 1a,25(OH) 2 D 3 -mediated repression of IEX-1 gene expression.
Discussion
In this study, we addressed the mechanism by which vitamin D 3 regulates expression of the proliferationpromoting gene, IEX-1. We have previously shown that 1a,25(OH) 2 D 3 inhibits keratinocytic cellular growth (Haugen et al., 1996) . We also observed that 1a,25(OH) 2 D 3 reduces IEX-1 mRNA concentrations in HaCaT cells and brings about the movement of IEX-1 protein from the nucleus to the perinuclear region and cytoplasm . We have now identi®ed a DNA sequence element in the human IEX-1 gene promoter that mediates transcriptional inhibition in response to 1a,25(OH) 2 D 3 . Our transient transfection data show that 1a,25(OH) 2 D 3 reduces IEX-1 promoter activities by at least 50% and the region responsible for this transcriptional eect is located 7575 and 7279 5' to the transcription start site. The 7575/7279 region contains two putative steroid hormone receptor elements which may mediate the 1a,25(OH) 2 D 3 -mediated repression of IEX-1 gene expression in HaCaT cells. We show that these elements mediate interactions with VDR/RXRa heterodimers, and that mutation of the element abrogates vitamin D 3 responsiveness. Hence, we have identi®ed a novel vitamin D 3 responsive element (VDRE) in the human IEX-1 promoter.
The VDRE in the human IEX-1 gene contains two steroid hormone response elements that are arranged in opposite orientation with three base pair apart from each other. Multiple negative VDREs have been previously characterized for several genes which encode bone-related proteins including the human and avian parathyroid hormone (PTH) (Demay et al., 1992; Mackey et al., 1996; Liu et al., 1996b) , the rat PTH related peptide (PTHrP) (Falzon, 1996; Kremer et al., 1996) , the mouse osteocalcin (Lian et al., 1997) , and the rat bone sialoprotein (BSP) genes (Kim et al., 1996) . VDREs can exert both positive and negative eects on transcription and several molecular determinants may in¯uence the ability of VDREs to enhance or suppress transcription of the target gene. VDRE function may be in¯uenced by the primary nucleotide composition of the steroid hormone half element and/ or the spacer between the two steroid half elements (Haussler et al., 1998; Towers and Freedman, 1998; Koszewski et al., 1999 Koszewski et al., , 2000 . The conformation and/ or polarity of the VDR/RXR heterodimer (Towers and Freedman, 1998; Koszewski et al., 2000) as well as cofactors interacting with liganded or unliganded VDR The cells were harvested 24 h later, and a luciferase reporter assay was performed. Promoterless PGL3-basic and promoter/enhancercontaining pGL3-Control vectors were used as negative and positive controls, respectively. The activities of the luciferase reporter were expressed as n-fold relative to the activity of promoterless pGL3-basic vector. The data shown are means of three independent experiments in duplicates, with at least two dierent plasmid preparations (Herdick and Carlberg, 2000; Rachez and Freedman, 2000) are major determinants for vitamin D 3 responsiveness. It has been shown that vitamin D 3 represses transcription of the human PTH gene by heterodimerization with a co-repressor dierent from RXR. This negative human PTH VDRE diers from a classical DR3-VDRE and contains substitutions in the 3' half element (Mackey et al., 1996) . Other studies using the avian PTH VDRE have revealed that modi®cation of these nucleotides could reverse the negative eect of vitamin D 3 to positive regulation (Koszewski et al., 1999) . Nucleotide speci®c dierences that alter VDRE function among species are also evident for the osteocalcin gene. The rat and human osteocalcin VDREs mediate positive regulation, but when two bases are substituted in the 5' steroid half element, repression of the promoter activity was observed upon treatment with vitamin D 3 (Lian et al., 1997) . It will be of interest to investigate what alterations of the VDRE in human IEX-1 promoter can in¯uence repressor element function.
Since IEX-1 has been shown to regulate cell survival and proliferation, we suggest that IEX-1 may play a role in HaCaT keratinocyte-like-cell growth and dierentiation and that 1a,25(OH) 2 D 3 may reduce cellular growth via a reduction in IEX-1 mRNA and a change in the intracellular distribution of IEX-1 protein. Vitamin D 3 is anti-proliferative and promotes dierentiation in several cell lines such as HL60 (Reitsma et al., 1983) , neuroblastoma , osteoblast (Wu et al., 1997) and HaCaT (Haugen et al., 1996) cell lines. Vitamin D 3 appears to aect dramatically the maturation and functions of certain normal and neoplastic epithelial cells (Berger et al., 1988; Giuliano et al., 1991; Mehta et al., 1997; Saunders et al., 1993; Peehl et al., 1994) . Also, the proliferation of number of epithelially derived cancer cells (e.g., mammary, prostate and colon) is inhibited in culture by 1a,25(OH) 2 D 3 (Haussler et al., 1998) . This eect in neoplastic cells may be related to the reported ability of liganded VDR to arrest cells at the G 1 stage by in¯uencing cell cycle regulatory proteins, such as p21 and p27, to control cell growth factors such as c-myc (Reitsma et al., 1983; O'Connell and Simpson, 1995) , c-fos (Candeliere et al., 1996) and IEX-1 (Kumar et al., 1998) , or to elicit apoptosis by Figure 5 VDRE/RXRa heterodimer formation is required for the DNA-protein interaction. Electrophoretic mobility shift assay was performed using anity puri®ed full-length human vitamin D receptor (hVDR) and human retinoic acid X receptor a (hRXRa) expressed in E. coli. The radio-labeled wild type vitamin D response element of IEX-1 oligonucleotides interacts with proteins with the both hVDR and hRXRa were present (marked as+) in the binding reaction mixture. For competition experiments, a 20-fold molar excess of unlabeled oligonucleotides of wild type VDRE of IEX-1 (wt VDRE) or mouse osteopontin vitamin D response element (mOP-VDRE) was used for speci®c competition and unlabeled oligonucleotides of mutant VDRE of IEX-1 (mut VDRE) was used for non-speci®c competition electorphoretic mobility shift assay downregulating Bcl-2 (Elstner et al., 1996; SimboliCampbell et al., 1997) . Recently, we found that IEX-1 is the down-stream target of tumor suppressor gene, p53 (Im et al., 2002) , which activates apoptotic signaling pathway. Since 1a,25(OH) 2 D 3 increases p53 expression (Mathiasen et al., 1999) and because p53 inhibits IEX-1 expression (Im et al., 2002) , it is possible that the eects of the hormone on IEX-1 gene expression are mediated by two mechanisms. The ®rst involves direct IEX-1 gene repression via the newly de®ned VDRE in the IEX-1 gene promoter and the second, indirect mechanism, involves p53-mediated repression of IEX-1.
In conclusion, we have identi®ed a novel VDRE in the human IEX-1 gene promoter region. Suppressive transcriptional regulation of the IEX-1 gene promoter by 1a,25(OH) 2 D 3 through a speci®c and unique VDRE is likely to be an important signaling by which 1a,25(OH) 2 D 3 controls cellular proliferation and dierentiation.
Materials and methods
General
Concentrations of 1a,25(OH) 2 D 3 (a gift from Dr M Uskokovic, Homann-LaRoche, Nutley, NJ, USA) in ethanol (e 265 nm =18 200 M 71 cm 71 ) and oligonucleotides and nucleic acids in water or aqueous buer were determined by ultraviolet spectroscopy with a BECKMAN COUL-TER TM DU-7400 spectrophotomer (Beckman Instruments, Fullerton, CA, USA). The cDNA for human vitamin D receptor (hVDR) was provided by JW Pike (University of Wisconsin, Madison, WI, USA), and the cDNA for human retinoid X receptor a (hRXRa) was provided by R Evans (The Salk Institute for Biological Studies, La Jolla, CA, USA). Oligonucleotide synthesis was performed in the Mayo Molecular Biology Core Facility. DNA sequences were con®rmed by dideoxy DNA sequencing using an automated sequencer and the Sanger dideoxy sequencing method (Sanger et al., 1977) . PCR reagents were from Roche (Indianapolis, IN, USA) and PCR was carried out on a Perkin Elmer Cetus DNA Thermal Cycler 480 (Norwalk, CT, USA). Cloning for expression, screening and initial puri®ca-tion of the fusion proteins (VDR, RXRa) were carried out using the GST Gene Fusion System (Pharmacia Biotech, Inc.
Piscataway, NJ, USA) . Puri®cation of PCR products and plasmids and DNA digest utilized Wizard DNA miniprep columns (Promega Corp.).
Cell cultures and transient transfection
Keratinocyte-like cell line, HaCaT cells (referred as HaCaT) were maintained in Dulbecco modi®ed Eagle medium (DMEM) (Life Technologies, Inc. Rockville, MD, USA) supplemented with 10% fetal calf serum as described earlier (Boukamp et al., 1988) . For transfection, cells were plated 24 h prior to transfection at a density of 1610 6 cells per plate in 6-well plates and transiently transfected with 1 mg of IEX-1 promoter/®re¯y Luciferase (Luc) reporter gene constructs using 6 ml of FuGene 6 transfection reagent (Roche Inc, Indianapolis, IN, USA). Renilla luciferase construct, PRL-TK (100 ng) (Promega Inc, Madison, WI, USA) was included as an internal control for transfection eciency. Cells were harvested 24 h post-transfection, and luciferase activity was assayed using the Dual luciferase reporter assay system (Promega Inc, Madison, WI, USA) and a luminometer as described by the manufacturers (Turner Designs, Sunnyvale, CA, USA). All transfection experiments were repeated four or more times in duplicate utilizing plasmids that were independently prepared at least twice.
Deletional and site-directed mutagenesis
The IEX-1 promoter construct, 71419pIEX-1 fused into chloramphenicol acetyltransferase report gene (CAT), was kindly provided by Dr MO Jung (Georgetown University Medical Center, Washington, DC, USA). The 71419pIEX-1 DNA fragment was fused into ®re¯y luciferase reporter gene plasmid (pGL3-basic) at the KpnI and NheI restriction enzyme sites. For deletional mutagenesis, 7575, 7279, 7200, 7150, 7110 and 770pIEX-1, PCR products were generated with sense and antisense primers containing appropriate restriction enzyme sites and template 71419pIEX-1 DNA (Table 1) . These PCR products were cloned into the pCR2.1-TOPO cloning vector using TOPO TA cloning kit (Invitrogen Inc, Rockville, MD, USA) followed by subcloning into the pGL3-basic promoterless plasmid at the KpnI and NheI restriction enzyme sites. Sitedirected mutagenesis was performed using QuikChange TM Site-Directed Mutagenesis Kit (Strategene Inc, La Jolla, CA, USA). In brief, sense and antisense oriented primers complementary to each other and bearing SalI enzyme restriction site were mixed with template plasmid for the generation of PCR product. This was followed by DpnI Table 1 The PCR primers used for the deletional and site-directed mutagenesis of IEX-1 promoter. The primer sequences are from 5' to 3'. The core response elements replaced by SalI restriction enzyme sites are indicated in bold lowercase letters
Primer Sequences
71IEX-rev TCA GTT GCT AGC AAG GCC AGG TGA GGG TCG GCT GC NheI 7575IEX-f CTA CTA GAA GAA GGA CGG AGG GAG 7279IEX-F TAA AGT GAG CCC CTC TCC AGG TGC CAC 7200IEX-f CAC ACA CTC ACA ACG TGC AGT TGG GCG 7150IEX-f GTC TCC ACC CAC TCC CTT TGT TTA ATC GTC 7110IEX-f CAA CCG CTC CCC AGC TGC GGG AGG AGG AGT 770IEX-f GAA GGA CCC GCC CAA TTT TCA GGA GCA CA mutVDRE/71419 and mut VDRE/7575 GGA AGC TGA GGC AGG AAA ATC GCT gtcga C AGG G tcgac GGG GTT GCA GTG AGC CGA GAT CGC GCC restriction enzyme digestion (378C for 3 h) to remove the template plasmid. The unmethylated PCR product was transformed into E. coli XL1-blue competent cells (Strategene Inc, La Jolla, CA, USA), and selected on ampicillin (100 mg/ ml) agar plates. The DNA sequences of all constructs were veri®ed by KpnI/NheI (IEX-1 promoter deletion constructs) or SalI (site-directed mutagenesis) restriction enzyme digestion followed by the dideoxy DNA sequencing using an automated sequencer and the Sanger dideoxy sequencing method (Sanger et al., 1977) . The PCR primers used for the promoter deletion constructs and site-directed mutagenesis are shown in Table 1 .
Construction of vitamin D response element reporter plasmid and mammalian expression vectors
The mouse osteopontin vitamin D response element fused to ®re¯y luciferase reporter gene, pPON.VDRE.tk-GL-3, was previously described (Lutz et al., 2000) . Human RXRa (hRXRa) and VDR (hVDR) cDNAs with appropriate restriction sites at the 5' and 3' termini were obtained from plasmids containing the cDNAs by the PCR method using the primers for hVDR: forward 5'-GACATCgaattcATG-GAGGCAATGGCGGCCAGCACT-3' and reverse 5'-TATGCGaagcttAATCAGGA-GATCTCATTGCC-AAACAC-3'. The primers for hRXRa: forward 5'-CCAT-GT tctag-aA TGGACACCAAACATTTCCTGCCG -3' and reverse 5'-TCTCAGaagcttCTAAG-CATTTGGTGCGGC-GC-3' (restriction enzyme recognition sequences are italicized in lower case, EcoRI and HindIII for hVDR and XbaI and HindIII for hRXRa). The hVDR and hRXRa mammalian expression vector was prepared by inserting hVDR cDNA and hRXRa cDNA into the plasmid, pcDNA3.1 (Invitrogen, Rockville, MD, USA), at the EcoRI/HindIII and XbaI/ HindIII restriction enzyme sites, respectively to give CMVhVDR or CMV-hRXRa. The resulting mammalian expression plasmid was veri®ed by restriction enzyme digestion and DNA sequencing.
Protein expression and purification
PCR and synthesis of human vitamin D receptor (hVDR) and human retinoid X receptor a (hRXRa) expression vectors was carried out as previously described (Craig et al., 1997; Veenstra et al., 1998a,c) . Full-length hVDR and human RXRa were expressed and puri®ed as previously described at low temperature (208C) as GST fusion proteins in the pGEX-4T-2 vector using E.coli BL21 cells (Pharmacia Biotech, Piscataway, NJ, USA). The fusion protein eluted from glutathione sepharose was cleaved with thrombin and further puri®ed by ion exchange chromatography. The fulllength hVDR was puri®ed by Mono Q chromatography (Mono Q HR 10/10) (Pharmacia Biotech, Piscataway, NJ, USA) using running buer (50 mM Tris, 10 mM DTT, pH 8.0). Protein was eluted by a gradient of 0 ± 1 M NaCl in running buer. Characterization of puri®ed proteins was carried out by SDS-PAGE performed as previously described (Veenstra et al., 1998a,c) . Puri®ed RXRa consisted of residues 26 ± 462 in hRXRa (26 ± 462 RXRa), residues 1 ± 25 having been cleaved by thrombin at an internal thrombin site (Gly24-Arg25-Gly26). Puri®ed hVDR consisted of the fulllength protein (residues 1 ± 427) with an N-terminal Gly-Ser extension derived from the thrombin cleavage site in the GST fusion protein. The molecular masses as determined by electrospray ionization mass spectrometry were consistent with the other characterized data (Veenstra et al., 1998a,c) . Protein concentrations were determined using the Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA).
Electrophoretic gel mobility shift assays
Double-stranded oligonucleotides generated from the singlestranded oligonucleotides listed in Table 1 were used as electrophoretic mobility shift assay probes. Oligonucleotides (25 mM) were annealed in 20 mM Tris, 100 mM NaCl, pH 7.5 by boiling 10 min 1008C then cooling to *228C over 1.5 h. One hundred pmoles of these double-stranded DNAs were 32 P-labeled using [g-32 P]dATP (15 ml, 3000 Ci/mmol) (Amersham Pharmacia Biotech) and T4 polynucleotide kinase (25U) (Invitrogen Life Technologies, Rockville, MD, USA) in 16forward reaction buer (70 mM Tris (pH7.6), 10 mM MgCl 2 , 100 mM KCl, 1 mM 2-mercaptoethanol) at 378C for 1 h. Labeled DNA was puri®ed on NENSORB 20 nucleic acid puri®cation columns (Du Pont Co., Wilmington, DE, USA) and eluted in 50% ethanol. To 1.5 ± 3.0610 6 c.p.m. (4 2.4 pmoles) 32 P-labeled double stranded VDREs were added to 10 ml gel shift reaction buer (reaction buer: 20 mM Tris, 2 mM dithiothreitol (DTT), 150 mM NaCl, 0.2 mM ZnSO4, 10% gylcerol, pH 7.5 with 0.2 mg/ml poly dI-dC) and 5 ml full-length hVDR (0.2 mg/ml in 30 mM Tris, 5 mM DTT, 200 mM NaCl, 0.13 mM ZnSO4, 7% glycerol, pH *7.8) with 5 ml in 16gel shift buer without poly dI-dC (=VDR alone) or 5 ml full-length hRXRa (0.2 mg/ml in *16gel shift buer without poly dI-dC (=RXRa alone) or 5 ml of each protein (=hVDR+hRXRa). Reactions were incubated for 40 min at room temperature (*228C) before loading to 5% acrylamide (19 : 1, acrylamid:bis-acrylamide), 0.56TBE, 1% glycerol gels. Gels were pre-run at 200 V for 40 min then at 300 V for *50 min at room temperature after loading. X-ray ®lm was exposed to dried gels. 
